Top Cannabis Stocks for September 2024: US Industry Leaders to Watch
The US cannabis industry continues to experience rapid growth, making marijuana stocks a popular choice for investors. 2023 the US cannabis market was valued at approximately $33 billion. Experts predict it will grow to over $50 billion by 2028. This growth is driven by the increasing legalization of recreational and medical cannabis across states. Recent news about federal cannabis reform, including potential banking access for cannabis businesses, has further boosted investor confidence. As more states and the federal government explore legalization, many anticipate significant changes that could expand the industry.
For investors, proper risk management is essential when considering cannabis stocks. The sector is known for its volatility, requiring a strategic approach. Utilizing technical analysis, such as studying price charts and market trends, helps identify key buying and selling points. Investors should also diversify their portfolios to mitigate risk. By combining technical analysis with a well-thought-out risk management plan, investors can better navigate the complexities of marijuana stocks.
As the cannabis industry grows in the United States, investors seek the next big opportunities. Three stocks stand out among the many options available. These companies have strong market presences, robust financials, and a clear vision for future growth. Below are the top three US marijuana stocks that should be on your watchlist in September.
[Read More] Marijuana Stocks To Watch Today In The Cannabis Sector
Best Marijuana Stocks to Add to Your Watchlist for September 2024
- Glass House Brands Inc. (OTC: GLASF)
- Planet 13 Holdings Inc. (OTC: PLNH)
- Cansortium Inc. (OTC: CNTMF)
Glass House Brands Inc.
Glass House Brands Inc. (GLASF) is a major player in the cannabis industry, particularly in California. The company has focused heavily on vertical integration, which handles every part of the process, from cultivation to retail. Currently, Glass House operates five retail dispensaries across California. They have also acquired several greenhouse facilities, allowing them to expand production. Their Santa Barbara facility is one of the largest cannabis greenhouses in the United States, providing them with a major advantage in production volume.
This company’s strategy centers around controlling costs while maintaining high-quality products. With its extensive presence in California, the largest cannabis market in the US, Glass House is in a prime position for future growth. Also, its dispensary network is growing, and its distribution channels are expanding, making it a formidable player in the market. Given its expansion plans, Glass House is a stock worth watching closely.
In terms of financials, Glass House reported steady revenue growth over the past few quarters. For Q2 2024, the company announced revenues of approximately $45.6 million, a significant increase from previous quarters. The company’s focus on cost control has also improved gross margins. Operating costs, however, remain a concern as the company is still scaling operations. Additionally, Glass House has been reducing its debt and strengthening its financial standing. Increasing revenue and improving balance sheets make Glass House a stock with long-term potential. As Glass House continues to scale, profitability seems closer on the horizon.
[Read More] 2 Top Marijuana Stocks To Watch This Upcoming Week
Planet 13 Holdings Inc.
Planet 13 Holdings Inc. (PLNH) is known for its massive cannabis superstores, attracting tourists and locals alike. Based in Las Vegas, Planet 13 operates the largest dispensary in the world. This flagship store is a popular destination, and the company is expanding its footprint in other key states. They have also opened a second superstore in Orange County, California, further cementing their presence in major US markets. The company’s focus on creating a unique customer experience has made it one of the most recognizable brands in the cannabis space.
In addition to its two flagship locations, Planet 13 has plans to expand into other states with legal cannabis markets. The company is eyeing opportunities in markets like Florida and New York, where it could replicate its superstore model. Planet 13’s strategy is centered around providing an immersive, high-end shopping experience, setting it apart from more traditional cannabis retailers.
Financially, Planet 13’s Q2 2024 revenue was reported at $29.9 million, showing a steady growth trajectory. Despite the pandemic, their Las Vegas superstore continued to perform well, and the California store is gaining momentum. The company’s gross margins remain at 57%, demonstrating effective cost control. Additionally, Planet 13 has a healthy balance sheet, with manageable debt levels and sufficient liquidity to fund its expansion plans. However, the company is still investing heavily in growth, which has impacted net income. Profitability is expected to improve as it expands, making Planet 13 a strong contender for future growth.
[Read More] September 2024 Watchlist: Leading Cannabis REITs for Investment
Cansortium Inc.
Cansortium Inc. (CNTMF) is a medical cannabis company with a stronghold in Florida, one of the largest medical cannabis markets in the US. Cansortium operates under the Fluent brand, with 30 retail dispensaries in Florida. The company is also expanding its presence in Texas, Michigan, and Pennsylvania, aiming to become a multi-state operator. Its focus on the medical cannabis sector has allowed it to capture a loyal customer base in states with well-established programs.
In Florida, Cansortium continues to lead with high-quality products and strong customer retention. The company is working on expanding its product lines and increasing cultivation capacity. With more than half of its revenue coming from Florida, Cansortium’s growth potential is closely tied to the state’s expanding medical cannabis market. The company has also laid the groundwork for future growth in emerging markets like Texas, where it sees significant opportunities as medical cannabis gains acceptance.
On the financial side, Cansortium reported Q2 2024 revenues of $23.5 million, marking a year-over-year increase of 18%. The company’s gross margins are currently at 58%, reflecting its efficient production process. Cansortium has also been focused on reducing operating expenses, which has helped improve profitability. In addition, the company is in a solid financial position with positive cash flow and a strategy to reduce debt. Although they are still in a growth phase, Cansortium’s focus on medical cannabis and expanding into new markets makes it a promising stock to watch as it aims to become a leading national operator.
[Read More] 2 Marijuana Stocks For Your September Watchlist
Top Cannabis Companies for Your Investment Portfolio
As the cannabis industry continues to expand across the US, companies such as Glass House Brands, Planet 13 Holdings, and Cansortium Inc. are steadily positioning themselves as market leaders. Not only do these stocks boast strong financials, but they also show promising growth potential and a solid market presence. Therefore, they are emerging as top contenders for any cannabis-focused portfolio. Moreover, with September approaching, now is an ideal time to keep these companies on your watchlist as they offer significant potential investment opportunities.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
